The Evidence Files: PRP Injections for Foot & Ankle — State of the Evidence

The Evidence Files: PRP Injections for Foot & Ankle — State of the Evidence The Promise and the Hype Platelet rich plasma (PRP) has captured the imagination of athletes and patients seeking advanced regenerative treatments. The idea sounds straightforward: concentrate growth factors from your own blood and inject them into damaged tissue to stimulate healing. Professional athletes swear by it. Media coverage suggests it's revolutionary. But what does the clinical research actually show? The evidence on PRP for foot and ankle injuries is evolving, cautiously optimistic in some conditions, and not yet definitive in others. Understanding the current state of the science helps you make informed decisions about whether PRP makes sense for your specific problem. How PRP Works (In Theory and Practice) Platelet rich plasma is prepared by drawing your blood, spinning it in a centrifuge to concentrate platelets and growth factors, then injecting the concentrated solution at the site of injury. Platelets contain numerous growth factors—PDGF, VEGF, FGF, and others—that theoretically stimulate tissue repair, reduce inflammation, and promote new blood vessel formation. The mechanism is biologically plausible and supported by laboratory research. In clinical practice, PRP quality varies substantially. Different preparation methods yield different platelet concentrations (sometimes 3x baseline, sometimes 20x baseline). Some protocols include additional components like white blood cells or fibrin; others don't. This variability is important: studies of "PRP" may actually be comparing quite different products, making interpretation challenging. Think of PRP like "concentrated vegetable juice"—the concept is simple, but the actual product varies widely depending on preparation methods. What the Evidence Shows Plantar Fasciitis Multiple randomized controlled trials have examined PRP for chronic plantar fasciitis. Results have been mixed but generally supportive. A systematic review found that PRP injected groups showed pain reduction comparable to or slightly better than corticosteroid injection at 3–6 months, with more durable benefit at 12 months in some studies. One meta analysis of plantar fasciitis RCTs found a modest advantage for PRP over controls, but the effect size was small to moderate. Published data suggests PRP is reasonable for chronic plantar fasciitis that has failed conservative care, though it's not dramatically superior to established treatments like corticosteroid injection combined with physical therapy. Achilles Tendinopathy Chronic Achilles tendon pain (tendinopathy) is a common, frustrating condition. Several randomized trials examined PRP for Achilles tendinopathy, comparing it to corticosteroid injection and/or sham injection (placebo). Results have been inconsistent: some trials showed meaningful improvement with PRP, others showed PRP was no better than placebo. A Cochrane systematic review of regenerative medicine for Achilles tendinopathy concluded that evidence was insufficient to recommend PRP as standard treatment, though it noted that results were "suggestive" of benefit. The takeaway: PRP may help, but we can't yet say it definitively does based on current evidence. Ankle Sprains and Ligament Injuries Anterior talofibular ligament (ATFL) sprains are common, and some residual pain and instability can persist despite conventional rehabilitation. Early stage evidence on PRP for acute ankle sprains is sparse. A small number of randomized trials examined PRP injected at the time of acute injury or shortly after. Results have been promising but not conclusive—some showed faster return to sport, others showed minimal difference. The evidence here remains preliminary; larger, well designed trials are ongoing. Metatarsalgia and Morton's Neuroma Limited evidence exists for PRP in these conditions. A handful of small studies examined PRP for Morton's neuroma (nerve pain between metatarsal heads) and metatarsalgia (ball of foot pain). Results have been mixed, and no definitive recommendations exist from major societies. Some podiatrists report clinical benefit, but randomized evidence is lacking. Important Caveats Systematic reviews and meta analyses on PRP for musculoskeletal conditions repeatedly identify methodological limitations in published studies: small sample sizes, variable PRP preparation protocols, heterogeneous outcome measures, and high rates of bias. This heterogeneity makes it difficult to draw firm conclusions. Additionally, many studies are funded by companies that profit from PRP, introducing financial bias. Independent, well funded randomized trials are ongoing but incomplete. Published evidence also suggests that PRP is not a "magic bullet." In studies comparing PRP alone to multimodal conservative care (physical therapy, activity modification, biomechanical correction), combined approaches show comparable or superior outcomes. PRP appears to work best when combined with ongoing reh